Brokerages remain bullish on several mid-cap stocks across sectors, with 10 companies receiving more than 20 ‘buy’ calls from analysts, according to Trendlyne data. These include major names such as Federal Bank, Ashok Leyland, Aurobindo Pharma, Lupin, and Voltas, with analysts projecting up to 25% upside from current levels.